image
Healthcare - Biotechnology - NASDAQ - CN
$ 27.06
1.46 %
$ 2.68 B
Market Cap
-8.73
P/E
BALANCE SHEET
1.04 B ASSETS
-15.07%
240 M LIABILITIES
37.60%
796 M EQUITY
-23.86%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Zai Lab Limited
image
Current Assets 940 M
Cash & Short-Term Investments 806 M
Receivables 65.3 M
Other Current Assets 67.8 M
Non-Current Assets 96.7 M
Long-Term Investments 9.22 M
PP&E 68.7 M
Other Non-Current Assets 18.8 M
Current Liabilities 203 M
Accounts Payable 113 M
Short-Term Debt 14.2 M
Other Current Liabilities 75.9 M
Non-Current Liabilities 37.1 M
Long-Term Debt 8.05 M
Other Non-Current Liabilities 29.1 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 790.2 1 008.5 964.1 442.1 75.9 63.0 229.7 83.9 13.2
Short Term Investments 16.3 0 445.0 744.7 200.0 200.3 0 0 0
Receivables 65.3 48.6 54.8 5.2 3.8 90 K 0 0 0
Inventory 44.8 31.6 19.0 13.1 6.0 3.82 K 0 0 0
Other Current Assets 23.0 35.7 18.0 10.9 6.7 5.7 1.0 0.1 69 K
Total Current Assets 939.6 1 124.3 1 500.9 1 216.0 292.5 269.1 230.6 84.1 13.2
PP&E 68.7 78.8 58.3 47.1 36.9 20.8 12.0 2.7 0.7
Intangible Assets 16.5 8.4 9.7 9.4 8.8 0.3 20.1 K 7 K 2.52 K
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 9.2 6.4 15.6 1.3 2.4 3.1 1.7 0.5 1
Other Long Term Assets 2.3 2.2 0.8 0.7 0.5 8.6 5.4 3.1 1
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 1 036.3 1 220.1 1 610.0 1 297.6 355.2 302.0 249.6 88.9 13.9
LIABILITIES
Accounts Payable 113.0 66.0 126.2 62.6 22.7 37.4 9.0 0.5 1.5
Short Term Debt 14.2 14.1 11.9 10.4 10.8 3.6 0 0 0
Other Current Liabilities 58.9 46.5 46.1 24.0 13.2 7.8 3.1 4.6 2.5
Total Current Liabilities 203.1 139.8 192.9 98.0 46.6 48.8 12.1 5.2 3.9
Long Term Debt 8.0 13.3 9.6 13.4 11.0 0 0 0 0
Deferred Tax Income 0 (21.4) (27.5) (16.9) (2.9) 0 0 0 0
Other Liabilities 0.3 0 27.5 16.9 2.9 0 0 134.5 28.3
Total Liabilities 240.2 174.5 230.0 128.3 60.5 50.9 14.5 140.5 32.3
EQUITY
Common Stock 6 K 6 K 6 K 5 K 4.09 K 3.48 K 3 K 579 533
Retained Earnings (2 196.0) (1 861.4) (1 418.1) (713.6) (444.7) (249.6) (110.6) (60.2) (22.7)
Other Accumulative Comprehensive Income/Loss 37.6 25.7 (23.6) (14.5) 4.6 2.7 0.4 (0.7) (0.1)
Total Equity 796.1 1 045.6 1 380.0 1 169.3 294.7 251.1 235.2 (51.6) (18.4)
Total Liabilities and Equity 1 036.3 1 220.1 1 610.0 1 297.6 355.2 302.0 249.6 88.9 13.9
SHARES OUTSTANDING
Common Shares Outstanding 96.6 95.8 93.0 77.7 87.8 52.6 21.8 49.3 49.3